Brief: Amniotics Secures Funding Of Sek 4,8 Million From Vinnova
20/01/2022 08:25
Jan 20 (Reuters) - Amniotics AB (publ) AMNI.ST :
* AMNIOTICS SECURES FUNDING OF SEK 4,8 MILLION FROM VINNOVA
TO
DEVELOP STEM CELL THERAPIES
Source text for Eikon: ID:nMFN9h6VVX
Further company coverage: AMNI.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Amniotics AB (publ)
See all newsBrief: Swedish Companies Registration Office Authorises Magle Group, Amniotics Merger Plan
Brief: Amniotics H1 Net Revenue SEK 2.5 Million
Brief: Amniotics Gets Conditional Approval To Delist From Nasdaq First North Growth Market
Brief: Amniotics To Delist From Nasdaq First North Growth Market Upon Magle Group Merger Completion
Brief: Magle Chemoswed, Amniotics Adopt Merger Plan